Outcome of Stroke Patients with Cancer and Nonbacterial Thrombotic Endocarditis
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background and Purpose Nonbacterial thrombotic endocarditis (NBTE) is a cause of stroke in cancer. However, clinical characteristics and outcomes in stroke patients with cancer-associated NBTE are not well known. Methods We included consecutive patients with stroke and active cancer over a 9-year period who underwent echocardiography. We retrospectively compared clinical characteristics and presence of metastasis between patients with NBTE, those with cryptogenic etiologies, and those with determined etiologies. We also investigated mortality and stroke events during the 6-month follow-up. Results Among the 245 patients, 20 had NBTE, 96 had cryptogenic etiologies, and 129 had determined etiologies. Metastasis was seen in all 20 patients (100%) with NBTE, 69.8% in patients with cryptogenic etiology, and 48.8% in patients with or determined etiology. During the 6-month follow-up, 127 patients (51.8%) developed stroke and/or died (death in 110 [44.9%] and stroke events in 55 [22.4%]). Patients with NBTE showed significantly higher mortality (80%) and stroke occurrence (50%) than those with cryptogenic etiologies (mortality 54.2%, stroke 25.0%, log-rank P=0.006) and determined etiologies (mortality 32.6%, stroke 16.3%, log-rank P<0.001). In a multivariate Cox proportional hazard analysis, the presence of NBTE was independently associated with composite outcomes of mortality and stroke events (hazard ratio, 1.941; 95% confidence interval, 1.052 to 3.690). Conclusions NBTE should be suspected as a potential cause of stroke in patients with metastatic cancer. Patients with NBTE have a high risk of recurrent stroke and mortality. Future studies are necessary to determine strategies to reduce stroke recurrence in patients with NBTE.
Abstract
Background and Purpose Nonbacterial thrombotic endocarditis (NBTE) is a cause of stroke in cancer. However, clinical characteristics and outcomes in stroke patients with cancer-associated NBTE are not well known. Methods We included consecutive patients with stroke and active cancer over a 9-year period who underwent echocardiography. We retrospectively compared clinical characteristics and presence of metastasis between patients with NBTE, those with cryptogenic etiologies, and those with determined etiologies. We also investigated mortality and stroke events during the 6-month follow-up. Results Among the 245 patients, 20 had NBTE, 96 had cryptogenic etiologies, and 129 had determined etiologies. Metastasis was seen in all 20 patients (100%) with NBTE, 69.8% in patients with cryptogenic etiology, and 48.8% in patients with or determined etiology. During the 6-month follow-up, 127 patients (51.8%) developed stroke and/or died (death in 110 [44.9%] and stroke events in 55 [22.4%]). Patients with NBTE showed significantly higher mortality (80%) and stroke occurrence (50%) than those with cryptogenic etiologies (mortality 54.2%, stroke 25.0%, log-rank P=0.006) and determined etiologies (mortality 32.6%, stroke 16.3%, log-rank P<0.001). In a multivariate Cox proportional hazard analysis, the presence of NBTE was independently associated with composite outcomes of mortality and stroke events (hazard ratio, 1.941; 95% confidence interval, 1.052 to 3.690). Conclusions NBTE should be suspected as a potential cause of stroke in patients with metastatic cancer. Patients with NBTE have a high risk of recurrent stroke and mortality. Future studies are necessary to determine strategies to reduce stroke recurrence in patients with NBTE.
참고문헌 (31)
- Navi BB, "Risk of arterial thromboembolism in patients with cancer", J Am Coll Cardiol, 70, pp.926~938 (2017)
- 김경섭, "Histopathological Findings of Intracranial Thrombi in Nonbacterial Thrombotic Endocarditis", 대한뇌졸중영문학회지, 19(3), pp.367~369 (2017), 대한뇌졸중학회
- Navi BB, "Ischemic stroke in cancer patients : a review of an underappreciated pathology", Ann Neurol, 83, pp.873~883 (2018)
- Oh Young Bang, "Cancer-Related Stroke: An Emerging Subtype of Ischemic Stroke with Unique Pathomechanisms", 대한뇌졸중영문학회지, 22(1), pp.1~10 (2020), 대한뇌졸중학회[DOI]
- Reagan TJ, "The thrombotic syndrome associated with carcinoma. A clinical and neuropathologic study", Arch Neurol, 31, pp.390~395 (1974)
- Chen L, "Myocardial and cerebral infarction due to nonbacterial thrombotic endocarditis as an initial presentation of pancreatic adenocarcinoma", Arch Pathol Lab Med, 128, pp.1307~1308 (2004)
- Yamane A, "Multiple ischemic strokes caused by nonbacterial thrombotic endocarditis because of gallbladder cancer : a case report", J Stroke Cerebrovasc Dis, 23, pp.1727~1729 (2014)
- Bonnerot M, "Cerebral ischemic events in patients with pancreatic cancer: a retrospective cohort study of 17 patients and a literature review", Medicine (Baltimore), 95, pp.e4009~ (2016)
- Navi BB, "New diagnosis of cancer and the risk of subsequent cerebrovascular events", Neurology, 90, pp.e2025~e2033 (2018)
- Rogers LR, "Cerebral infarction from non-bacterial thrombotic endocarditis. Clinical and pathological study including the effects of anticoagulation", Am J Med, 83, pp.746~756 (1987)
- Park H, "Histological features of intracranial thrombi in stroke patients with cancer", Ann Neurol, 86, pp.143~149 (2019)
- Gay LJ, "Contribution of platelets to tumour metastasis", Nat Rev Cancer, 11, pp.123~134 (2011)
- Deppisch LM, "Non-bacterial thrombotic endocarditis : clinicopathologic correlations", Am Heart J, 92, pp.723~729 (1976)
- Taccone FS, "First-ever stroke as initial presentation of systemic cancer", J Stroke Cerebrovasc Dis, 17, pp.169~174 (2008)
- Navi BB, "Cryptogenic subtype predicts reduced survival among cancer patients with ischemic stroke", Stroke, 45, pp.2292~2297 (2014)
- Erdur H, "In-hospital stroke recurrence and stroke after transient ischemic attack : frequency and risk factors", Stroke, 46, pp.1031~1037 (2015)
- Cho HJ, "Transoesophageal echocardiography in patients with acute stroke with sinus rhythm and no cardiac disease history", J Neurol Neurosurg Psychiatry, 81, pp.412~415 (2010)
- Lee AY, "Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer", N Engl J Med, 349, pp.146~153 (2003)
- Yoo J, "Poor longterm outcomes in stroke patients with asymptomatic coronary artery disease in heart CT", Atherosclerosis, 265, pp.7~13 (2017)
- Yoo J, "Short-term outcome of ischemic stroke patients with systemic malignancy", Stroke, 50, pp.507~511 (2019)
- el-Shami K, "Nonbacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis, and treatment", Oncologist, 12, pp.518~523 (2007)
- Ji Hoe Heo, "Pathophysiologic and Therapeutic Perspectives Based on Thrombus Histology in Stroke", 대한뇌졸중영문학회지, 22(1), pp.64~75 (2020), 대한뇌졸중학회[DOI]
- Schlesinger M, "Role of platelets and platelet receptors in cancer metastasis", J Hematol Oncol, 11, pp.125~ (2018)
- Xu XR, "Cancer and platelet crosstalk : opportunities and challenges for aspirin and other antiplatelet agents", Blood, 131, pp.1777~1789 (2018)
- Jurasz P, "Platelet: cancer interactions. Mechanisms and pharmacology of tumour cellinduced platelet aggregation", Br J Pharmacol, 143, pp.819~826 (2004)
- Nieswandt B, "Lysis of tumor cells by natural killer cells in mice is impeded by platelets", Cancer Res, 59, pp.1295~1300 (1999)
- Egan K, "Living in shear : platelets protect cancer cells from shear induced damage", Clin Exp Metastasis, 31, pp.697~704 (2014)
- Bal S, "Relationship of endocarditis, disseminated intravascular coagulation, and embolic signals in cancer with stroke", Ann Neurol, 71, pp.146~ (2012)
- Navi BB, "Recurrent thromboembolic events after ischemic stroke in patients with cancer", Neurology, 83, pp.26~33 (2014)
- Merkler AE, "Diagnostic yield of echocardiography in cancer patients with ischemic stroke", J Neurooncol, 123, pp.115~121 (2015)
- Dutta T, "Yield of transesophageal echocardiography for nonbacterial thrombotic endocarditis and other cardiac sources of embolism in cancer patients with cerebral ischemia", Am J Cardiol, 97, pp.894~898 (2006)